AI-PROGNOSIS set up consistent recruitment protocols, secured regulatory approvals, and tackled early operational challenges during the launch of its first clinical study (dBM-DEV).

This update highlights early recruitment progress, protocol amendments, and the foundations laid for validating digital biomarkers in Parkinson’s disease.

Read the full report on Zenodo: https://zenodo.org/records/15542634